John W. Wine

456 total citations
9 papers, 393 citations indexed

About

John W. Wine is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John W. Wine has authored 9 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in John W. Wine's work include Immunotherapy and Immune Responses (5 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). John W. Wine is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). John W. Wine collaborates with scholars based in United States, Japan and Netherlands. John W. Wine's co-authors include Hideo Yagita∥, Mark J. Smyth, Robert H. Wiltrout, Thomas J. Sayers, Alan D. Brooks, Sally E. Spence, Jonathan R. Keller, Anil Shanker, Yoshihiro Hayakawa and Naoko Seki and has published in prestigious journals such as Blood, Immunity and The Journal of Immunology.

In The Last Decade

John W. Wine

9 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John W. Wine United States 7 226 184 113 78 35 9 393
Ilaria Cattarossi Italy 11 336 1.5× 309 1.7× 154 1.4× 64 0.8× 26 0.7× 14 569
Changchuin Mao United States 11 303 1.3× 217 1.2× 165 1.5× 41 0.5× 40 1.1× 20 573
Kai Herrmann Germany 8 213 0.9× 293 1.6× 79 0.7× 145 1.9× 26 0.7× 8 538
Naoyuki Anzai Japan 13 226 1.0× 216 1.2× 131 1.2× 128 1.6× 32 0.9× 24 487
Didier Bordereaux France 11 169 0.7× 269 1.5× 117 1.0× 55 0.7× 50 1.4× 16 450
K Utsumi Japan 6 253 1.1× 133 0.7× 145 1.3× 34 0.4× 29 0.8× 7 451
Diane Razanajaona France 11 323 1.4× 171 0.9× 95 0.8× 36 0.5× 18 0.5× 15 486
Jessica Cantrell United States 8 291 1.3× 78 0.4× 160 1.4× 57 0.7× 18 0.5× 10 396
Ivana Heřmanová Czechia 9 132 0.6× 198 1.1× 97 0.9× 39 0.5× 36 1.0× 16 406
Claire Mazumdar United States 4 316 1.4× 241 1.3× 289 2.6× 81 1.0× 33 0.9× 4 585

Countries citing papers authored by John W. Wine

Since Specialization
Citations

This map shows the geographic impact of John W. Wine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Wine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Wine more than expected).

Fields of papers citing papers by John W. Wine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Wine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Wine. The network helps show where John W. Wine may publish in the future.

Co-authorship network of co-authors of John W. Wine

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Wine. A scholar is included among the top collaborators of John W. Wine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Wine. John W. Wine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shanker, Anil, Alan D. Brooks, Kristen M. Jacobsen, et al.. (2009). Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity. Cancer Research. 69(16). 6615–6623. 38 indexed citations
2.
Shanker, Anil, Ari D. Brooks, John W. Wine, et al.. (2008). Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody. JNCI Journal of the National Cancer Institute. 100(9). 649–662. 69 indexed citations
3.
Winkler-Pickett, Robin, Howard A. Young, James M. Cherry, et al.. (2008). In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses. The Journal of Immunology. 180(7). 4495–4506. 77 indexed citations
4.
Ortaldo, John R., Anna Mason, Jami Willette‐Brown, et al.. (2007). Modulation of lymphocyte function with inhibitory CD2: Loss of NK and NKT cells. Cellular Immunology. 249(1). 8–19. 2 indexed citations
5.
Wine, John W., Linzhao Cheng, Fabio Candotti, et al.. (2003). In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals. Blood. 102(3). 843–848. 27 indexed citations
6.
Seki, Naoko, Yoshihiro Hayakawa, Alan D. Brooks, et al.. (2003). Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.. PubMed. 63(1). 207–13. 92 indexed citations
7.
Ortiz, Mariaestela, John W. Wine, N Lohrey, et al.. (1999). Functional Characterization of a Novel Hematopoietic Stem Cell and Its Place in the c-Kit Maturation Pathway in Bone Marrow Cell Development. Immunity. 10(2). 173–182. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026